Constellate Proteomics

Constellate Proteomics aims to reduce the cost of protein therapeutics, through innovations in product quality analysis and AI-supported process optimization.

Our current core analysis technology enables therapeutics developers to assess multiple critical quality attributes of protein therapeutics, in minutes, on extremely small unprocessed bioreactor samples. We will offer this capability in the COSMO, a benchtop device that fully automates the analysis process.